Bioinformatic analysis revealed that BIRC2 could bind to UBR4, whereas mass spectrometry revealed that NAP1L1 could bind to UBR4 in HCC cells with overexpression of NAP1L1. The gene discussed is NAP1L1; the disease is hepatocellular carcinoma.